~
查詢

宏碁智醫股份有限公司

宏碁智醫是宏碁集團的子公司，應用資通訊專長，專注於人工智慧及大數據分析技術，與醫院及醫療相關產業進行跨領域合作，設計及開發智慧醫療產品，將產品導入醫療照護場域，並推廣到國際市場。

長佳智能股份有限公司

長佳智能 結合： 「 AI解決架構師 」 「 資深臨床醫師 」 「 巨量資料科學的專業人員 」 針對醫療上的需求以人工智慧為工具，提升 診斷準確度協助醫療決策，實現精準醫療、 健康大數據管理與醫療科技服務。

德必碁生物科技股份有限公司

德必碁生物科技股份有限公司其母公司為澳洲交易所(ASX)上市公司TBG Diagnostics Limited(Code:TDL)，母公司主要股東為台灣上櫃公司(3176)基亞生物科技與台灣上市公司長興材料(1717)。

德必碁生物科技成立於1997年3月13日,專注於分子診斷檢驗產品與自動化設備研發，並在中國廈門與美國德州設立生產據點與研發中心。產品銷售遍及美、德、義、中、印等22個國家. 已取得ISO 13485、FDA 510(k)、CE Mark、台灣衛生署查驗登記等體外診斷試劑(IVD)認證，為亞洲第一家產銷HLA分型試劑的公司,並擁有ASHI認證實驗室(亞洲僅有五家公司取得ASHI認證資格)

行動基因生技股份有限公司

ACT Genomics is a leading precision oncology company headquartered in Taiwan with extended footprints in China, Japan, Hong Kong and Singapore. With our certified NGS platform and comprehensive genomic profiling, we help patients find the right treatments. At the same time, we collaborate with bio-pharmaceutical companies to accelerate clinical trials in drug development and CDX development. Our expertise in bioinformatics and medical interpretation enables us to deliver comprehensive and comprehensible medical reports and build cancer genomics database.

瀚源生醫股份有限公司

瀚源生醫創立於2016年，致力於發展應用導向、具高靈敏度的BioFET平台，即時監測健康狀態，以提供精準醫療所需的資訊。瀚源生醫的平台可有效應用於收集基因變異及蛋白質表現異常等資訊，來建立針對生物分子調控之動態檢測，幫助監測與診斷複雜的疾病。
Founded in 2016, Helios Bioelectronics, Inc. is developing an application-driven and highly sensitive BioFET platform, enabling real-time monitoring of health status for precision medicine.  The platform serves to collect information such as biologically significant genetic aberrations and altered protein expressions to establish dynamic profiling of the molecular regulations for monitoring and diagnostics of complex diseases.

鈦隼生物科技股份有限公司

鈦隼生物科技創立於2015年，擁有優秀的經營團隊，研發腦部手術導航系統，為STB、BIIP、國研院、工研院共同育成對象。
在臨床的需求下，鈦隼生物科技設計的產品為術中即時且準確的導引定位系統，幫助醫生在進行手術時，可獲取即時變化，並且搭配自動化機械手臂與智慧影像平台，精準，有效且安全的進行腦部外科手術，並降低手術出血與神經傷害風險，因而開發出外科手術用的『自動導航系統』。

Brain Navi Biotechnology was founded in 2015 with headquarters and primary research and development centers in Taiwan, located in Hsinchu Biomedical Science Park. It takes Taiwan’s advantages in R & D and production in the electronics industry, selecting Taiwan as a research and development and production base.

Pallianera Pharma

Pallianera Pharma is a clinical stage, biotech company with technologies in multiple fields including cosmetics, pain medicine, orthopedics, and oncology.

SYNG Pharmaceuticals Inc.

SYNG Pharmaceuticals Inc. (SYNG Pharma) is an emerging stage biotech developing a new first-in-class diagnostic test and therapeutic for endometriosis. SYNG Pharma's non-invasive ELISA Test EndoID is available for commercialization as a lab-based screening test.

CellChem Pharmaceuticals Inc.

CellChem Pharmaceuticals Inc. was formed in 2010, envisioned with becoming a global player in pharmaceuticals and developing into a one-stop solution in the segment of Rx, over-the-counters (OTCs), and nutraceutical products. CellChem acquired intellectual property (IP) from Pharmetics, formerly the largest OTC and vitamin manufacturer in Canada. CellChem’s acquisition of Pharmetics gave it a pool of close to 500 Health Canada approved products. CellChem has since partnered with the leading global generic company to market its products. CellChem currently exports to some global markets and aims to increase exports to even broader global markets.

Additive Design in Surgical Solutions (ADEISS) Cen

ADEISS is a leader in the provision of customized and patient-specific medical devices to the Canadian market through additive manufacturing. As an ISO 13485 compliant company holding a Medical Device Establishment License (MDEL), ADEISS works with leading researchers and clinicians to design, develop and 3D-print metal-based implants and surgical instruments for use in the orthopaedic, dental, and veterinary markets. The ADEISS team is now seeking investment support to help scale operations and expand market reach.

St Vincent’s Hospital Melbourne

St Vincent’s Hospital Melbourne is part of the St Vincent’s Health Australia, a $2 billion not-for-profit health and aged care provider. We’re the second largest healthcare provider with more than 30 facilities along the eastern seaboard. SVHM is one of five tertiary teaching hospitals in Victoria. Our clinical care is supported by an inspiring and very active translational research program:
Oncology / haematology – breast and lung cancer
Gastroenterology – NASH, hepatitis B/C, IBD
Neurosciences – epilepsy, Parkinson’s disease, neurosurgery
Cardiology – interventional, devices, clinical management
Endocrinology – diabetes, devices, complications
Renal medicine
Regenerative medicine
Immunology/inflammation/infection/sepsis
Orthopaedics – sarcoma, limb reconstruction
Respiratory – ɑ1 anti-trypsin deficiency
Bioengineering: stem cells, 3-D Printing

聖昕營養科技股份有限公司

聖昕營養科技有限公司成立於2003年10月，初期以代理豬隻飼料添加物、原料及飼料為主要業務，後來進一步跨足製造並銷售飼料及精料。
2006年有感於畜牧市場有朝向集團化的趨勢，市場經營勢必漸趨艱難，因此自創品牌"活菌豬”，期能走出一條新的道路，可惜由於經驗不足，且市場對品牌接受度仍低，經營2年後就中止此一事業。2008年與嘉一香食品合作，利用公司經營"活菌豬"時的飼料技術，生產出肉質鮮甜無腥味的豬肉，並且由公司做為養豬戶與嘉一香食品的橋樑，由養豬戶飼養好吃無藥殘的豬肉，嘉一香食品則做為屠宰與品牌銷售商。可是當時養豬產業面對環狀病毒與藍耳病的困擾，因此在肉豬供應及品質上，時常有無法克服的問題。當時業界普遍希望，以提升細胞抗氧化力或活化免疫細胞，來解決此一困境，卻效果有限。在偶然的機會下接觸到病原辨識初乳蛋白(Pathological Recognition Colostrum Protein, PRCP)，其可在腸道非特異的與病原黏合、進入腸黏膜並且釋放訊息給免疫細胞，使免疫細胞產生抗體來對抗病原，由於其病原辨識初乳蛋白(PRCP)乃利用自體產生”抗體”以對抗疾病，與原來提升細胞抗氧化力或活化免疫細胞的解決方案不同，因此就將此一解決方案應用動物飼養中，也產生了令人驚喜的成果。由於病原辨識初乳蛋白(PRCP)的驚喜，現今公司除了仍做為畜產品牌的創造者與整合者外，更全力朝向動物(人類)疾病的預防、治療及新藥的開發發展。

我的公司未列在內，需要更新資訊？

聯繫環球生技»

生醫資料庫

熱門公司 查看更多

投資雷達 查看更多

公司說明會


TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務